期刊文献+

奥氮平和利醅酮治疗老年脑卒中后精神行为症状的临床对比分析 被引量:7

下载PDF
导出
摘要 目的探讨奥氮平和利醅酮治疗老年脑卒中后精神行为症状的临床效果与满意度。方法 80名住院老年脑卒中后精神行为症状患者平分为两组-治疗组与对照组各40例,对照组采用奥氮平治疗,治疗组采用利醅酮治疗。结果对照组的空腹血糖、总胆固醇及三酰甘油在治疗6周后均升高,与治疗前比较差异有统计学意义(P<0.05);治疗组的空腹血糖、总胆固醇及三酰甘油在治疗6周后升高,与治疗前比较差异无统计学意义(P>0.05)。治疗组的满意率明显高于对照组(P<0.05)。结论相对于奥氮平来说,利醅酮治疗老年脑卒中后精神行为症状对血糖血脂的影响比较少,且患者对治疗的满意度高,值得推广应用。
作者 王清峰
出处 《中国实用医药》 2011年第24期163-164,共2页 China Practical Medicine
  • 相关文献

参考文献6

二级参考文献18

  • 1Mukherjee S, Decina P, Bocola V, et al. Diabetes mellitus in schizophrenic patients. Compr Psychiatry, 1996, 37(1): 68.
  • 2Waitzkin L. A survey for unknown diaetics in a mental hospital, Ⅱ Men from age fifty. Diabetes, 1966, 15(3): 164.
  • 3Brambilla F, Guastalla A, Guerrini A, et al. Glucose-insulin metabolism in chronic schizophrenia. Dis Nerv System, 1976, 37(2): 98.
  • 4Braceland FJ, Meduna LI, Vaichulis JA. Delayed action of insulin in schizophrenia. Am J Psychiatry, 1945, 102(3): 108.
  • 5Kasanin J. The blood sugar curve in mental diseae. Arch Neurol and Psychitary, 1926, 16: 414.
  • 6Benton D. Owens DS. Blood glucose and human memory. Psychopharmacology, 1993, 113(1) : 83.
  • 7Craft S, Zallen G, Baker LD. Glucose and memory in mild senile dementia of the Alzheimer type. J Clin Exp Neuropsychol, 1992, 14(2) : 253.
  • 8Newcomer JW, Craft S, Fucetola R, et al. Glucose-induced increases in memory performance in schizophrenia. Schizophmia Bulletin, 1999, 25(2) : 315.
  • 9Craft S, Murphy C, Werntrom J. Glucose effects on complex and nonmemory tasks: the influence of age, sex and glucoregulatory response.Psychobiology, 1994, 22(2): 95.
  • 10Kuusisto J, Koivisto K, Mykkanen K, et al. Associtaion between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study, Br Med J, 1997, 315(7115): 1045.

共引文献40

同被引文献43

  • 1解恒革,王鲁宁,于欣,王炜,杨丽娟,马腾霄,张晓红,杨丽君,许贤豪,彭丹涛,张振馨,魏镜,王荫华,贾建平,管小亭,冯峰.北京部分城乡社区老年人和痴呆患者神经精神症状的调查[J].中华流行病学杂志,2004,25(10):829-832. 被引量:48
  • 2中华医学会精神科分会.中国精神障碍分类与诊断标准[M].济南:山东科学技术出版社,2001.91-132.
  • 3中华医学会精神科分会编.中国精神障碍分类与诊断标准(CCMD-3)[M]. 济南:山东科学技术出版社,2001.75.
  • 4李培德,李丽.两种药物治疗老年痴呆症的临床疗效观察[J].心理医生(下半月版),2012(7):295.
  • 5安成革.奥氮平治疗老年痴呆43例临床分析[J].中国保健营养(上旬刊),2013,23(7):3912.
  • 6WoodmanI. Osteoporosis: Linking osteoporosis with Alzheimer disease. Nat Rev Rheumatol, 2013, 68 (7-8) : 412-417.
  • 7Reisberg B, Auer SR, Monteiro IM. Behavioral Patholigy in Alzheimer's Disease (BEHAVE-AD) Rating Scale. Interna- tional Psychogeriatrics, 1996, 8 (Suppl 3) : 301-308.
  • 8Venuto CS,Mc Garry A,Ma Q,et al.Pharmacologic approaches to the treatment of Huntington's disease[J].Movement Disorders,2012,27(1):31-41.
  • 9Zhang X,Yan X,Gorman J,et al.Perioperative hyperglycemia is associated with postoperative neurocognitive disorders after cardiac surgery[J].Neuropsychiatr Dis Treat,2014,10:361-370.
  • 10Sandler M.Alzheimer's disease[J].Scientist,2015,17(4):4.

引证文献7

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部